| IQVIA HLDGS DL-,01 |
| USA |
| Gesundheit |
| US46266C1053 / A2JSPM |
| QTS (Frankfurt) / IQV (NYSE) |
| FRA:QTS, ETR:QTS, QTS:GR, NYSE:IQV |
| S&P500 |
| https://www.iqvia.com/ |
|
IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company operates three primary divisions..
>Volltext.. |
| 24244.64 Mio. EUR |
| 36332.29 Mio. EUR |
| 14126.47 Mio. EUR |
| 2967.56 Mio. EUR |
| 1178.36 Mio. EUR |
| 6.87 EUR |
| 14088.35 Mio. EUR |
| 1715.56 Mio. EUR |
| 2299.54 Mio. EUR |
| 0.26 |
| -6.72% |
| -12.69% |
| - |
| - |
| - |
| - |
| IQVIA |
| 19.03.26 |
|
||||
|
||||
|